WS #13299

From 500 msgs · 5 key-dev

AstraZeneca explores ~$400B acquisition of Bristol Myers Squibb, a major pharma consolidation signal (ongoing from previous cycle, no new data).

Pharma mega-merger exploration

AstraZeneca explores ~$400B acquisition of Bristol Myers Squibb, a major pharma consolidation signal (ongoing from previous cycle, no new data).

Full world state #13299 →